Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Beijian Zhang"'
Publikováno v:
Genes and Diseases, Vol 8, Iss 6, Pp 746-758 (2021)
N6-methyladenosine (m6A) RNA methylation is an emerging area of epigenetics, which is a reversible and dynamic modification mediating by ‘writers’ (methylase, adding methyl groups, METTL3, METTL14, and WTAP), ‘erasers’ (demethylase, deleting
Externí odkaz:
https://doaj.org/article/77b571b7f4f84c65a47703ae05439774
Autor:
Beijian Zhang, Hao Jiang, Jian Wu, Yun Cai, Zhen Dong, Yongchao Zhao, Qinfeng Hu, Kai Hu, Aijun Sun, Junbo Ge
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/b8e94a170fee427ebb8fe82c885314ee
Autor:
Yongchao Zhao, Jingjing Hu, Xiaolei Sun, Kun Yang, Lebing Yang, Lingqiu Kong, Beijian Zhang, Fuhai Li, Chaofu Li, Bei Shi, Kai Hu, Aijun Sun, Junbo Ge
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 5, Pp n/a-n/a (2021)
Abstract Background Post‐ischemic angiogenesis is critical for blood flow recovery and ischemic tissue repair. N6‐methyladenosine (m6A) plays essential roles in numerous biological processes. However, the impact and connected mechanism of m6A on
Externí odkaz:
https://doaj.org/article/6919bf077a134f8a9f73a25233f841fb
Autor:
Beijian Zhang, Yamei Xu, Xiaotong Cui, Hao Jiang, Wei Luo, Xinyu Weng, Yun Wang, Yuhong Zhao, Aijun Sun, Junbo Ge
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disease, in which its pathogenesis is very complex and far from defined. Here, we explored the N6-methyladenosine (m6A) RNA methylation alteration in patients with
Externí odkaz:
https://doaj.org/article/7df48c7996a14fc6be1e8d83853970d6
Autor:
Wei Luo, Xiaoyi Zou, Yidan Wang, Zheng Dong, Xinyu Weng, Zhiqiang Pei, Shuai Song, Yongchao Zhao, Zilun Wei, Rifeng Gao, Beijian Zhang, Liwei Liu, Peiyuan Bai, Jin Liu, Xiang Wang, Tingwen Gao, Yang Zhang, Xiaolei Sun, Hang Chen, Kai Hu, Shisuo Du, Aijun Sun, Junbo Ge
Publikováno v:
Circulation Research. 132
Background: Doxorubicin is an effective chemotherapy drug for treating various types of cancer. However, lethal cardiotoxicity severely limits its clinical use. Recent evidence has indicated that aberrant activation of the cytosolic DNA-sensing cycli
Autor:
Qinfeng Hu, Hang Chen, Cheng Shen, Beijian Zhang, Xinyu Weng, Xiaolei Sun, Jin Liu, Zhen Dong, Kai Hu, Junbo Ge, Aijun Sun
Publikováno v:
Alcoholism: Clinical and Experimental Research. 46:707-723
Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is a key enzyme in alcohol metabolism. The ALDH2*2 mutations are found in approximately 45% of East Asians, with 40% being heterozygous (HE) ALDH2*1/*2 and 5% homozygous (HO) ALDH2*2/*2. Studies have sho
Publikováno v:
Genes and Diseases, Vol 8, Iss 6, Pp 746-758 (2021)
Genes & Diseases
Genes & Diseases
N6-methyladenosine (m6A) RNA methylation is an emerging area of epigenetics, which is a reversible and dynamic modification mediating by 'writers' (methylase, adding methyl groups, METTL3, METTL14, and WTAP), 'erasers' (demethylase, deleting methyl g
Publikováno v:
Current Pharmaceutical Design. 25:3751-3761
Exercise has long been recognized as a beneficial living style for cardiovascular health. It has been applied to be a central component of cardiac rehabilitation for patients with chronic heart failure (CHF), coronary heart disease (CHD), post-acute
Autor:
Junbo Ge, Lebing Yang, Lingqiu Kong, Xiaolei Sun, Beijian Zhang, Jingjing Hu, Aijun Sun, Kai Hu, Fuhai Li, Yongchao Zhao, Kun Yang, Bei Shi, Chaofu Li
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 5, Pp n/a-n/a (2021)
Clinical and Translational Medicine
Clinical and Translational Medicine
Background Post‐ischemic angiogenesis is critical for blood flow recovery and ischemic tissue repair. N6‐methyladenosine (m6A) plays essential roles in numerous biological processes. However, the impact and connected mechanism of m6A on post‐is
Autor:
Jian Wu, Hao Jiang, Hu Qinfeng, Yongchao Zhao, Zhen Dong, Aijun Sun, Beijian Zhang, Ge Junbo, Kai Hu, Cai Yun
Publikováno v:
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)